Calamos Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Calamos Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-26,500	Closed	-$4.38M	–	1089
2021 Q2	$4.38M	Hold	26,500	–	–	0.02%	602
2021 Q1	$4.06M	Buy	+26,500	New	+$3.6M	0.02%	581

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Calamos Advisors's PRAH Position: Q3 2021 in Review

Calamos Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 26,500 shares — an estimated $4.38M sold.

Calamos Advisors first reported a position in PRAH in Q1 2021 and held it in 2 quarters. The position peaked at $4.38M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Calamos Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Calamos Advisors sold 26,500 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $4.38M.
Calamos Advisors first reported a position in PRA Health Sciences, Inc. in Q1 2021 and held it in 2 quarters.
Calamos Advisors's PRA Health Sciences, Inc. position peaked at $4.38M in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.